Yan C, Chen J, Tang H, Deng C, Zhang Q, Wang X
J Inflamm (Lond). 2023; 20(1):34.
PMID: 37864223
PMC: 10588139.
DOI: 10.1186/s12950-023-00359-6.
Pandey M
Biomedicines. 2023; 11(4).
PMID: 37189685
PMC: 10135900.
DOI: 10.3390/biomedicines11041067.
Aytenfisu T, Campbell H, Chakrabarti M, Amzel L, Gabelli S
Curr Top Microbiol Immunol. 2022; 436:3-49.
PMID: 36243838
DOI: 10.1007/978-3-031-06566-8_1.
Sun C, Wiestner A
Hematol Oncol Clin North Am. 2021; 35(4):827-845.
PMID: 34174988
PMC: 8269747.
DOI: 10.1016/j.hoc.2021.03.010.
Nurnberg B, Beer-Hammer S
Biomolecules. 2019; 9(9).
PMID: 31480354
PMC: 6770443.
DOI: 10.3390/biom9090427.
Duvelisib: a phosphoinositide-3 kinase δ/γ inhibitor for chronic lymphocytic leukemia.
Vangapandu H, Jain N, Gandhi V
Expert Opin Investig Drugs. 2017; 26(5):625-632.
PMID: 28388280
PMC: 5584596.
DOI: 10.1080/13543784.2017.1312338.
Different phosphoinositide 3-kinase isoforms mediate carrageenan nociception and inflammation.
Pritchard R, Falk L, Larsson M, Leinders M, Sorkin L
Pain. 2015; 157(1):137-146.
PMID: 26313408
PMC: 4711388.
DOI: 10.1097/j.pain.0000000000000341.
Abrogation of immune complex glomerulonephritis by native carboxypeptidase and pharmacological antagonism of the C5a receptor.
Alexander J, Chaves L, Chang A, Dighe S, Jacob A, Quigg R
Cell Mol Immunol. 2015; 13(5):651-7.
PMID: 26166765
PMC: 5037280.
DOI: 10.1038/cmi.2015.45.
The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection.
Thomas K, Valenzuela N, Reed E
Trends Mol Med. 2015; 21(5):319-29.
PMID: 25801125
PMC: 4424065.
DOI: 10.1016/j.molmed.2015.02.004.
The biology behind PI3K inhibition in chronic lymphocytic leukaemia.
Ortiz-Maldonado V, Garcia-Morillo M, Delgado J
Ther Adv Hematol. 2015; 6(1):25-36.
PMID: 25642313
PMC: 4298491.
DOI: 10.1177/2040620714561581.
PI3Kγ inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice.
Li H, Park D, Abdul-Muneer P, Muneer P, Xu B, Wang H
Neuroscience. 2013; 253:89-99.
PMID: 24012746
PMC: 9529370.
DOI: 10.1016/j.neuroscience.2013.08.051.
Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells.
Schreiner J, Kretschmer D, Klenk J, Otto M, Buhring H, Stevanovic S
J Immunol. 2013; 190(7):3417-26.
PMID: 23460735
PMC: 3608756.
DOI: 10.4049/jimmunol.1202563.
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?.
Schwab I, Nimmerjahn F
Nat Rev Immunol. 2013; 13(3):176-89.
PMID: 23411799
DOI: 10.1038/nri3401.
The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases.
Banham-Hall E, Clatworthy M, Okkenhaug K
Open Rheumatol J. 2012; 6:245-58.
PMID: 23028409
PMC: 3460535.
DOI: 10.2174/1874312901206010245.
The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice.
Alexander J, Chaves L, Chang A, Quigg R
Kidney Int. 2012; 82(9):961-8.
PMID: 22832515
PMC: 3472160.
DOI: 10.1038/ki.2012.249.
Regulation of alveolar macrophage p40phox: hierarchy of activating kinases and their inhibition by PGE2.
Bourdonnay E, Serezani C, Aronoff D, Peters-Golden M
J Leukoc Biol. 2012; 92(1):219-31.
PMID: 22544939
PMC: 3382311.
DOI: 10.1189/jlb.1211590.
A selective inhibitor reveals PI3Kγ dependence of T(H)17 cell differentiation.
Bergamini G, Bell K, Shimamura S, Werner T, Cansfield A, Muller K
Nat Chem Biol. 2012; 8(6):576-82.
PMID: 22544264
DOI: 10.1038/nchembio.957.
C5a-regulated CCAAT/enhancer-binding proteins β and δ are essential in Fcγ receptor-mediated inflammatory cytokine and chemokine production in macrophages.
Yan C, Zhu M, Staiger J, Johnson P, Gao H
J Biol Chem. 2011; 287(5):3217-30.
PMID: 22147692
PMC: 3270976.
DOI: 10.1074/jbc.M111.280834.
A recombinant vaccine effectively induces c5a-specific neutralizing antibodies and prevents arthritis.
Nandakumar K, Jansson A, Xu B, Rydell N, Ahooghalandari P, Hellman L
PLoS One. 2010; 5(10):e13511.
PMID: 20975959
PMC: 2958150.
DOI: 10.1371/journal.pone.0013511.
C5a receptor enables participation of mast cells in immune complex arthritis independently of Fcγ receptor modulation.
Nigrovic P, Malbec O, Lu B, Markiewski M, Kepley C, Gerard N
Arthritis Rheum. 2010; 62(11):3322-33.
PMID: 20662064
PMC: 2970731.
DOI: 10.1002/art.27659.